Urine Testing Cups Market Summary
The market for urine testing cups is expected to increase at a compound annual growth rate (CAGR) of 6.69% from 2025 to 2030, from an estimated USD 1.33 billion in 2024 to USD 1.96 billion by 2030. The growing prevalence of drug addiction, the increasing use of urine testing for illness identification and chronic condition monitoring, technological improvements, and the rising need for point-of-care and home-based diagnostic tools are all contributing factors to the increase in demand for urine testing cups.
Key Market Trends & Insights
- The North American urine testing cup market held the largest revenue share—more than 38.95%—in 2024.
- The presence of prominent U.S.-based companies such as Thermo Fisher Scientific and Premier Biotech, Inc. is a significant driving factor for the urine testing cups market in the country.
- By sterility, sterile urine testing cups dominated the market with a revenue share of 79.54%.
- By product, urine testing cups segmented with temperature strips held the largest market in 2024.
- By application, the drug testing segment dominated the application landscape in the urine testing cups market in 2024.
Market Size & Forecast
- 2024 Market SizeUSD 1.33 Billion
- 2030 Projected Market SizeUSD 1.96 Billion
- CAGR (2025-2030)6.69%
- North AmericaLargest market in 2024
- Asia PacificFastest growing market
According to the Drugs Control Administration (DCA) in Hyderabad, there was a significant increase in the distribution and misuse of illicit and counterfeit substances, as seen by the 573 drug-related infractions in 2024 compared to just 56 in 2023. This involves the arrest of those involved in the distribution of psychoactive substances, including medical professionals, and the seizure of drugs valued at more than USD 1.3 million. These advancements highlight the increasing demand for effective, real-time drug detection instruments in law enforcement, healthcare, and the workplace. Because of their portability, quick findings, and capacity to identify a variety of illegal substances, urine testing cups are therefore expected to see a sharp increase in demand.
The market has grown significantly as a result of the notable increase in drug usage worldwide. For example, as the graph below illustrates, the World Drug Report 2024, which was released in June 2024, states that the number of drug users increased to 292 million in 2022, representing a 20% growth over the previous ten years. This increase, which is fueled by the pervasive use of drugs like cannabis and synthetic opioids, emphasizes the rising demand for efficient drug monitoring equipment. Furthermore, there is an urgent need for rapid and accurate testing techniques because an anticipated 7 million people will formally interact with law enforcement in 2022 for drug-related offenses. This is further supported by the graph's upward trend, which highlights the important function of urine testing cups in assisting with early identification, treatment, and preventive initiatives in both criminal justice and healthcare contexts. An estimated 35.5 million Americans have renal disease, of whom around 555,000 are receiving dialysis and approximately 815,000 are suffering from kidney failure, according to data provided by the American renal Fund in February 2025. Urine testing is becoming increasingly used for disease identification and long-term health monitoring, as seen by the dramatic increase in chronic renal disorders. Urine testing cups provide an effortless, non-invasive, and economical way to find renal impairment early on so that treatment can start on time. The need for routine screening tools, such as urine testing cups, is growing since kidney disease now affects more than 14% of American adults, disproportionately affecting people of color. These tools are essential for treating chronic health issues and assisting with preventive healthcare initiatives.
Market Concentration & Characteristics
The market is growing at a moderate rate, and this growth is accelerating. The market for urine testing cups is expanding as a result of the growing incidence of chronic illnesses, including renal disease, and the rising prevalence of drug use worldwide. Rising general health consciousness also increases the use of urine testing cups for regular checks. The need for quick, non-invasive, and affordable diagnostic instruments drives their broad use in the medical field and other industries.
Companies like Advin Biotech and Premier Biotech are providing cutting-edge features to improve usefulness and efficiency in the industry of urine testing cups, which is undergoing significant innovation. Advin Biotech's POCiT cup has a built-in container that keeps a clean, removable sample for meeting rules or further testing, making it especially helpful in busy places like pain labs by reducing the time needed for processing. Premier Biotech, meanwhile, has a line of quick, integrated test cups that emphasize precision, speed, usability, and drug panel customization. These developments highlight the market's dedication to next-generation diagnostic solutions by demonstrating a strong focus on enhancing user experience, compliance, and adaptability.
Urine testing cups must meet quality and safety criteria set by regulatory organizations including the Food and Drug Administration (FDA), Health Canada, the European Union, and others. Regulatory scrutiny varies accordingly, categorizing these devices into several groups based on the danger levels involved.
Due to the demand for broader product portfolios and improved technological capabilities, the market for urine testing cups has experienced a moderate amount of mergers and acquisitions. Businesses are lining up strategically to expand into new regional markets and improve distribution networks. While preserving competitive pricing and adhering to changing healthcare regulations, these consolidations foster innovation.
Urine test strips, disposable urine bags, and newly developed, cutting-edge diagnostic instruments are product alternatives to urine testing cups. Frequently used with separate collection containers, urine test strips offer rapid and affordable examination of a variety of parameters, including protein and glucose. Disposable urine bags, designed for hygienic and leak-proof collection, are particularly helpful in situations involving travel or remote care. Smart diagnostic tools, such as sensors built into toilets and smartphone-based readers, are also becoming more popular since they allow for easy, real-time urine analysis at home. Traditional urine testing cups are facing increasing competition from these alternatives, which provide increased functionality, privacy, and convenience.
Strategic investments and partnerships to address global healthcare concerns are driving the urine testing cup market's regional expansion. For example, Toyoda Gosei Co., Ltd. invested in Yuurea, Inc. in March 2024. Yuurea, Inc. is a firm that creates basic urine-based test kits for monitoring personal health. This action demonstrates the growing desire of large firms to boost their involvement in the healthcare industry and represents a growing commitment to preventative medicine. Companies like Toyoda Gosei are encouraging the regional expansion and acceptance of urine testing solutions, like urine testing cups, by encouraging the adoption of such technology throughout their networks, including employees and business partners.
Report Coverage & Deliverables
The PDF report & online dashboard will help you understand
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
Sterility Insights
Sterile urine testing cups dominated the market with a revenue share of 79.54% due to their critical role in ensuring sample integrity, accuracy, and safety across medical and forensic applications. The design of these cups prevents contamination, making them indispensable for diagnostic testing, drug screening, and disease monitoring where precise results are crucial. Their widespread use in hospitals, diagnostic labs, and law enforcement settings reflects growing regulatory emphasis on hygiene and reliability. As healthcare providers increasingly prioritize infection control and accurate diagnostics, the demand for sterile urine testing cups continues to outpace their non-sterile counterparts.
Non-sterile urine testing cups are expected to witness growth in the coming years due to their cost-effectiveness and suitability for low-risk or preliminary testing environments. Workplace drug testing, educational institutions, and at-home health monitoring, where sterility is less critical, are increasingly using these cups. Rising awareness and accessibility of self-testing options are also contributing to their growing demand.
Product Insights
Urine testing cups with temperature strips held the largest market in 2024 due to their enhanced ability to ensure sample authenticity and reliability. The integrated temperature strip helps verify whether a urine sample is freshly collected, a critical factor in drug screening and forensic testing where sample tampering is a concern. These cups are widely preferred in clinical, workplace, and law enforcement settings for their added layer of verification, which supports compliance with regulatory standards. As the demand for accurate and trustworthy testing continues to rise, products with built-in temperature validation remain the preferred choice across various sectors.
Furthermore, urine testing cups without temperature strips are gaining traction due to their affordability and suitability for non-critical testing environments. They are ideal for use in educational institutions, home testing, and wellness programs where strict verification protocols are not required. The simplicity and lower cost make them attractive for bulk screening initiatives. In addition, rising awareness of preventive healthcare is boosting their adoption in routine health monitoring.
Application Insights
Due to the extensive usage of multi-drug test cups like the iScreen, iCup, and E-Z Split Key, the drug testing sector dominated the application landscape in the urine testing cups market in 2024. These all-in-one screening devices are quite effective at identifying a variety of drugs from a single urine sample, such as cocaine, amphetamines, marijuana, opiates, and fentanyl. They are essential in law enforcement, rehabilitation facilities, healthcare settings, and businesses due to their convenience, dependability, and wide detection range. This market segment continues to hold a significant lead in demand as the necessity for quick and precise drug testing keeps growing, particularly in reaction to the rise in substance usage.
Improvements in medical diagnostics and rising demand for early, non-invasive testing techniques are expected to drive the disease detection segment's quickest compound annual growth rate (CAGR) in the urine testing cups market. The scope of urinalysis is growing well beyond its usual applications, as seen by Urteste S.A.'s creation of a prototype IVD test that can identify brain cancers from urine samples. Urine-based testing, a pipeline of 12 diagnostic tests that target major tumors that account for almost 70% of cancer deaths worldwide, is becoming a potent tool in oncology and the management of chronic diseases. The increasing use of urine testing cups to identify critical illnesses like kidney disease, diabetes, and liver diseases, as well as a larger trend toward preventative healthcare, are reflected in this development.
End-use Insights
The hospital and clinics segment held the largest share in 2024, driven by the high volume of diagnostic and drug screening procedures conducted in these settings. Urine testing cups are essential tools in hospitals and clinics for routine health checkups, disease detection, presurgical assessments, and monitoring of chronic conditions. They are widely used for pregnancy testing, helping clinicians make timely and accurate diagnoses. Their ability to deliver quick and precise results makes them a preferred patient choice. Moreover, the increasing patient load and growing emphasis on early diagnosis and preventive care further solidify the strong demand for urine testing cups.
The home use segment is expected to grow the fastest in the coming years, driven by technological innovations that bring clinical-grade testing to home settings. A prime example is the URINE CHECK-ER, the world’s first cup-type urine analyzer, recently recognized at the CES Innovation Awards 2025. This device revolutionizes at-home urinalysis by replacing traditional, unsanitary strip-type tests with a user-friendly, app-connected solution that offers medical institution-level accuracy. Its ability to digitize and store results for telemedicine or clinical follow-up makes it particularly valuable for individuals in remote or underserved regions, reflecting a broader shift toward decentralized and accessible healthcare solutions.
Regional Insights
The North American urine testing cups market held the largest revenue share of more than 38.95% in 2024. Research and innovation focused on early disease detection through non-invasive methods are driving the urine testing cups market in North America. For example, a news report from October 2024 says that new research from top schools like The University of Texas at Arlington, Chan-Zuckerberg Biohub, and Stanford University has shown that checking urine, especially looking at RNA and other cell materials, can help find early signs of diseases like cancer in the urinary system. Combined with rising concerns over drug use and a growing emphasis on preventive healthcare, these advancements significantly boost the demand for advanced urine testing solutions across the region.
U.S. Urine Testing Cups Market Trends
The presence of prominent U.S.-based companies such as Thermo Fisher Scientific and Premier Biotech, Inc. is a significant driving factor for the urine testing cups market in the country. These industry leaders are continuously advancing product innovation, expanding testing capabilities, and improving distribution networks. Their strong R&D investments and commitment to regulatory compliance ensure the availability of high-quality, reliable testing solutions, further fueling market growth across clinical, workplace, and home-use applications in the U.S.
Europe Urine Testing Cups Market Trends
The rising burden of Chronic Kidney Diseases (CKD), particularly in countries like the UK, significantly drives the urine testing cups market in Europe. According to the Economics-of-Kidney-Disease report published in June 2023, approximately 7.2 million people in the UK, over 10% of the population, live with various CKD stages. This growing prevalence points out the importance of regular and accessible diagnostic tools for early detection and monitoring. As non-invasive and cost-effective, urine testing cups are increasingly utilized in clinical and home settings to support kidney health management, contributing to the market’s expansion across Europe.
The urine testing cups market in the UK is being driven by the rising prevalence of drug use, particularly among adults. According to the Crime Survey for England and Wales (CSEW), an estimated 1.8% of people aged 16 to 59, approximately 610,000 individuals, were frequent drug users in the year ending March 2024. This growing concern around substance abuse is prompting increased demand for efficient, accurate, and rapid drug screening tools. As a result, urine testing cups are becoming essential in workplace testing, law enforcement, and healthcare settings, supporting broader public health and safety initiatives across the country.
The France urine testing cups market is projected to grow during the forecast period, driven by the increasing emphasis on preventive healthcare and routine medical screening. With rising public awareness of chronic diseases such as diabetes and kidney disorders, there is a growing demand for non-invasive, rapid diagnostic tools in both clinical and home settings. Government initiatives promoting regular health checkups and early detection programs further support the adoption of urine testing cups across the country.
The urine testing cups market in Germany is witnessing steady growth due to various factors, such as its strong healthcare infrastructure and the growing need for workplace drug testing and chronic disease monitoring. As one of Europe’s largest healthcare markets, Germany is witnessing increased utilization of urine-based diagnostics for conditions such as urinary tract infections, kidney disease, and diabetes. Additionally, the rise in substance use awareness and regulatory compliance in employment sectors is contributing to the growing demand for reliable and efficient urine testing solutions.
Asia Pacific Urine Testing Cups Market Trends
The Asia Pacific region is expected to register the highest CAGR during the forecast period, driven by significant growth in the urine testing cup industry. Key factors include rising demand for urine testing cups in Southeast Asian countries such as Indonesia, Malaysia, and Singapore. In addition, increasing healthcare expenditure in Singapore and Malaysia is expected to further boost market growth in the region. Moreover, the large patient population in countries such as India, China, and Japan can further propel the market growth over the forecast period.
The urine testing cups market in China is driven by several key factors, including the growing demand for rapid and reliable diagnostic tools in healthcare, workplace drug testing, and law enforcement. Chinese manufacturers, such as Safecare Biotech and those producing for international brands like Abbott Toxicology’s iSCREEN, are capitalizing on the increasing global need for cost-effective and scalable drug screening solutions. In addition, China’s strong manufacturing infrastructure, government support for medical device exports, and the rising prevalence of substance abuse testing in both domestic and international markets contribute to the expansion of this sector.
The Japan urine testing cups market is being driven by innovations aimed at improving clinical efficiency, safety, and reliability in diagnostic procedures. A key example is the introduction of TUBYCON-U, an all-in-one urine test cup designed with input from medical professionals. This device integrates a container and detachable tube, reduces the risk of sample mix-ups with pre-attached barcodes, and features a needle-free design that cuts medical waste disposal costs. Such advancements enhance the working conditions for medical staff and elevate patient safety, reflecting Japan’s broader focus on precision, automation, and healthcare quality—key factors propelling market growth in the region.
Latin America Urine Testing Cups Market Trends
The urine testing cups market in Latin America is growing steadily, fueled by rising concerns over drug abuse and the need for efficient screening tools across multiple sectors. Key contributors to this demand include the increasing enforcement of drug policies in workplaces, expanding healthcare access, and mandatory testing in competitive sports. Furthermore, advancements in rapid diagnostic technologies and supportive government health initiatives are making urine-based testing more accessible and widely adopted throughout the region
The market for urine testing cups in Brazil is expanding due to several key factors. Mandatory drug testing in sports to uphold fair play and athlete health further drives demand for reliable testing solutions. In addition, government initiatives aimed at controlling drug-related issues, coupled with advancements in point-of-care testing technologies, are enhancing the efficiency and accuracy of drug screening programs, contributing to the market's growth.
Middle East and Africa Urine Testing Cups Market Trends
The Middle East and Africa urine testing cups market is expanding due to several key factors. The rising prevalence of substance abuse, particularly opioids and illicit drugs, has heightened the need for effective drug screening methods across workplaces, healthcare institutions, and law enforcement agencies. Government initiatives aimed at controlling drug-related issues, coupled with stringent workplace safety regulations, are further propelling the demand for reliable and rapid diagnostic tools. In addition, technological advancements in point-of-care testing devices and the integration of innovative screening methods are enhancing the efficiency and accuracy of drug testing programs, contributing to the market's growth.
The Saudi Arabia urine testing cups market is growing rapidly due to strict anti-drug laws, increased workplace safety regulations, and government initiatives under Vision 2030 to combat drug abuse. Rising drug-related concerns and the need for efficient, on-the-spot testing solutions across sectors such as law enforcement, healthcare, and industry are further driving demand for reliable and rapid diagnostic tools.
The urine testing cups market in Kuwait is experiencing growth driven by several key factors. The increasing prevalence of substance abuse has heightened the need for effective drug screening methods, prompting both public and private sectors to adopt urine testing cups for workplace and clinical diagnostics. Government regulations mandating drug testing in safety-sensitive industries further bolster this demand. In addition, the expansion of healthcare infrastructure and the adoption of point-of-care testing technologies contribute to the market's upward trajectory.
Key Urine Testing Cups Company Insights
The leading companies in the urine testing cups market include BD, Abbott Toxicology, Labcon North America, Quest Diagnostics, Co-Innovation Biotech Co., Ltd., and Alfa Scientific Designs, Inc. MEDLINE, GLOBE SCIENTIFIC INC., CLIAWAIVED, CLARITY DIAGNOSTICS, SARSTEDT INC., and WONDFO are some of the major players in the urine testing cups market. Companies are expanding their portfolios of urine testing cups to gain a competitive advantage in the coming years.
Key Urine Testing Cups Companies
The following are the leading companies in the urine testing cups market. These companies collectively hold the largest market share and dictate industry trends.
- BD
- Abbott Toxicology
- Labcon North America
- Quest Diagnostics
- Co-Innovation Biotech Co., Ltd.
- Alfa Scientific Designs, Inc.
- Medline Industries, LP
- Globe Scientific Inc.
- CLIAWAIVED
- CLARITY DIAGNOSTICS
- Sarstedt inc
- Wondfo
Recent Developments
-
In September 2024, PreAnalytiX, a joint venture between QIAGEN and BD, launched the PAXgene Urine Liquid Biopsy Set, enabling non-invasive urine sample collection and immediate stabilization of cell-free DNA. This innovative solution includes a collection cup and a nucleic acid stabilizing tube, advancing liquid biopsy capabilities.
Urine Testing Cups Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 1.41 billion |
|
Revenue forecast in 2030 |
USD 1.96 billion |
|
Growth rate |
CAGR of 6.69% from 2025 to 2030 |
|
Base year for estimation |
2024 |
|
Actual data |
2018–2023 |
|
Forecast period |
2025-2030 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Sterility, product, application, end-use, region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA) |
|
Country scope |
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
|
Key companies profiled |
BD; Abbott Toxicology; Labcon North America; Quest Diagnostics; Co-Innovation Biotech Co., Ltd.; Alfa Scientific Designs, Inc.; Medline Industries, LP; GLOBE SCIENTIFIC INC; CLIAWAIVED; CLARITY DIAGNOSTICS; Sarstedt Inc; Wondfo |
|
Customization scope |
Free report customization (equivalent to up to 8 analysts' working days) with purchase. Changes or additions to the scope of the country, region, and segment are possible. |
|
Pricing and purchase options |
Avail yourself of customized purchase options to meet your exact research needs. Explore purchase options |
Global Urine Testing Cup Market Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, MIR has segmented the global urine testing cups market report on the basis of sterility, product, application, end-use, and region
-
Sterility Outlook (Revenue, USD Million, 2018-2030)
-
Sterile
-
NonSterile
-
-
Product Outlook (Revenue, USD Million, 2018-2030)
-
With Temperature Strip
-
Without Temperature Strip
-
-
Application Outlook (Revenue, USD Million, 2018-2030)
-
Drug Testing
-
Pregnancy Testing
-
Disease Detection
-
-
End-use Outlook (Revenue, USD Million, 2018-2030)
-
Hospitals & Clinics
-
Diagnostic Laboratories
-
Home Use
-
Others
-
-
Regional Outlook (Revenue, USD Million, 2018-2030)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
South Korea
-
Australia
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy